Entity Common Stock, Shares Outstanding of Applied Therapeutics, Inc. from Q2 2019 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Applied Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q2 2019 to Q3 2025.
  • Applied Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 12 Nov 2025 was 144M shares, a 24% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Applied Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 144M +27.9M +24% 12 Nov 2025 10-Q 13 Nov 2025
Q2 2025 144M +29.2M +25.4% 12 Aug 2025 10-Q 13 Aug 2025
Q1 2025 142M +35.7M +33.7% 11 Apr 2025 10-K 15 Apr 2025
Q3 2024 116M +39.1M +50.7% 06 Nov 2024 10-Q 07 Nov 2024
Q2 2024 115M +51.7M +81.9% 06 Aug 2024 10-Q 07 Aug 2024
Q1 2024 106M +57.8M +120% 05 Mar 2024 10-K 06 Mar 2024
Q3 2023 77.2M +29.2M +60.7% 08 Nov 2023 10-Q 09 Nov 2023
Q2 2023 63.1M +15.1M +31.5% 09 Aug 2023 10-Q 10 Aug 2023
Q1 2023 48.1M +21.9M +83.5% 22 Mar 2023 10-K 23 Mar 2023
Q3 2022 48.1M +21.8M +83.3% 08 Nov 2022 10-Q 09 Nov 2022
Q2 2022 48M +21.8M +83.4% 11 Aug 2022 10-Q 12 Aug 2022
Q1 2022 26.2M +206K +0.79% 09 Mar 2022 10-K 10 Mar 2022
Q3 2021 26.2M +3.73M +16.6% 10 Nov 2021 10-Q 12 Nov 2021
Q2 2021 26.2M +3.74M +16.7% 10 Aug 2021 10-Q 12 Aug 2021
Q1 2021 26M +4.04M +18.4% 12 Mar 2021 10-K 18 Mar 2021
Q3 2020 22.5M +5.35M +31.2% 11 Nov 2020 10-Q 12 Nov 2020
Q2 2020 22.4M +5.38M +31.6% 10 Aug 2020 10-Q 11 Aug 2020
Q1 2020 22M 12 Mar 2020 10-K 13 Mar 2020
Q3 2019 17.1M 01 Nov 2019 10-Q 13 Nov 2019
Q2 2019 17.1M 14 Jun 2019 10-Q 21 Jun 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.